Stigma experience among adolescents taking psychiatric medication

Derrick Kranke, Jerry Floersch, Lisa Townsend, Michelle Munson

Research output: Contribution to journalArticle

Abstract

This study investigated the experience of stigma among adolescents taking psychiatric medication for the treatment of a diagnosed mental illness. Although medications are intended to improve functioning and reduce mental disorder symptoms, little research has examined the potential stigma associated with taking them. This study recruited forty adolescents, ages 12-17, who met DSM-IV criteria for a mental health disorder and who were taking a psychiatric medication at the time of the study. Data were collected using a semi-structured interview instrument and were thematically analyzed using Link, Cullen, Struening, Shrout, and Dohrenwend's (1989) modified model of labeling theory. Results indicate that many adolescents did experience stigma. In particular, 90% of the sample endorsed at least one of Link et al.'s (1989) constructs of secrecy, shame, and limiting social interaction; four endorsed no stigma themes. Additional themes emerged indicating that the perceptions of adolescents' family members and school environments can accentuate their experience of stigma or serve as a protective barrier against it. The thematic findings of secrecy and shame were used to construct hypothetical models for how adolescents limited their social interaction.

Original languageEnglish (US)
Pages (from-to)496-505
Number of pages10
JournalChildren and Youth Services Review
Volume32
Issue number4
DOIs
StatePublished - Apr 2010

Fingerprint

Adolescent Psychiatry
medication
adolescent
Shame
Confidentiality
Interpersonal Relations
Mental Disorders
secrecy
shame
experience
Time and Motion Studies
Diagnostic and Statistical Manual of Mental Disorders
Psychiatry
mental disorder
Mental Health
interaction
mental illness
family member
Interviews
mental health

Keywords

  • Adolescence
  • Adolescent mental health
  • Mental illness stigma
  • Psychotropic treatment
  • Qualitative research

ASJC Scopus subject areas

  • Education
  • Developmental and Educational Psychology
  • Sociology and Political Science

Cite this

Stigma experience among adolescents taking psychiatric medication. / Kranke, Derrick; Floersch, Jerry; Townsend, Lisa; Munson, Michelle.

In: Children and Youth Services Review, Vol. 32, No. 4, 04.2010, p. 496-505.

Research output: Contribution to journalArticle

Kranke, Derrick ; Floersch, Jerry ; Townsend, Lisa ; Munson, Michelle. / Stigma experience among adolescents taking psychiatric medication. In: Children and Youth Services Review. 2010 ; Vol. 32, No. 4. pp. 496-505.
@article{8a838fdcf2ef481b8c0d686926292e38,
title = "Stigma experience among adolescents taking psychiatric medication",
abstract = "This study investigated the experience of stigma among adolescents taking psychiatric medication for the treatment of a diagnosed mental illness. Although medications are intended to improve functioning and reduce mental disorder symptoms, little research has examined the potential stigma associated with taking them. This study recruited forty adolescents, ages 12-17, who met DSM-IV criteria for a mental health disorder and who were taking a psychiatric medication at the time of the study. Data were collected using a semi-structured interview instrument and were thematically analyzed using Link, Cullen, Struening, Shrout, and Dohrenwend's (1989) modified model of labeling theory. Results indicate that many adolescents did experience stigma. In particular, 90{\%} of the sample endorsed at least one of Link et al.'s (1989) constructs of secrecy, shame, and limiting social interaction; four endorsed no stigma themes. Additional themes emerged indicating that the perceptions of adolescents' family members and school environments can accentuate their experience of stigma or serve as a protective barrier against it. The thematic findings of secrecy and shame were used to construct hypothetical models for how adolescents limited their social interaction.",
keywords = "Adolescence, Adolescent mental health, Mental illness stigma, Psychotropic treatment, Qualitative research",
author = "Derrick Kranke and Jerry Floersch and Lisa Townsend and Michelle Munson",
year = "2010",
month = "4",
doi = "10.1016/j.childyouth.2009.11.002",
language = "English (US)",
volume = "32",
pages = "496--505",
journal = "Children and Youth Services Review",
issn = "0190-7409",
publisher = "Elsevier Limited",
number = "4",

}

TY - JOUR

T1 - Stigma experience among adolescents taking psychiatric medication

AU - Kranke, Derrick

AU - Floersch, Jerry

AU - Townsend, Lisa

AU - Munson, Michelle

PY - 2010/4

Y1 - 2010/4

N2 - This study investigated the experience of stigma among adolescents taking psychiatric medication for the treatment of a diagnosed mental illness. Although medications are intended to improve functioning and reduce mental disorder symptoms, little research has examined the potential stigma associated with taking them. This study recruited forty adolescents, ages 12-17, who met DSM-IV criteria for a mental health disorder and who were taking a psychiatric medication at the time of the study. Data were collected using a semi-structured interview instrument and were thematically analyzed using Link, Cullen, Struening, Shrout, and Dohrenwend's (1989) modified model of labeling theory. Results indicate that many adolescents did experience stigma. In particular, 90% of the sample endorsed at least one of Link et al.'s (1989) constructs of secrecy, shame, and limiting social interaction; four endorsed no stigma themes. Additional themes emerged indicating that the perceptions of adolescents' family members and school environments can accentuate their experience of stigma or serve as a protective barrier against it. The thematic findings of secrecy and shame were used to construct hypothetical models for how adolescents limited their social interaction.

AB - This study investigated the experience of stigma among adolescents taking psychiatric medication for the treatment of a diagnosed mental illness. Although medications are intended to improve functioning and reduce mental disorder symptoms, little research has examined the potential stigma associated with taking them. This study recruited forty adolescents, ages 12-17, who met DSM-IV criteria for a mental health disorder and who were taking a psychiatric medication at the time of the study. Data were collected using a semi-structured interview instrument and were thematically analyzed using Link, Cullen, Struening, Shrout, and Dohrenwend's (1989) modified model of labeling theory. Results indicate that many adolescents did experience stigma. In particular, 90% of the sample endorsed at least one of Link et al.'s (1989) constructs of secrecy, shame, and limiting social interaction; four endorsed no stigma themes. Additional themes emerged indicating that the perceptions of adolescents' family members and school environments can accentuate their experience of stigma or serve as a protective barrier against it. The thematic findings of secrecy and shame were used to construct hypothetical models for how adolescents limited their social interaction.

KW - Adolescence

KW - Adolescent mental health

KW - Mental illness stigma

KW - Psychotropic treatment

KW - Qualitative research

UR - http://www.scopus.com/inward/record.url?scp=75949107898&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=75949107898&partnerID=8YFLogxK

U2 - 10.1016/j.childyouth.2009.11.002

DO - 10.1016/j.childyouth.2009.11.002

M3 - Article

VL - 32

SP - 496

EP - 505

JO - Children and Youth Services Review

JF - Children and Youth Services Review

SN - 0190-7409

IS - 4

ER -